Esperion Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ESPR on Nasdaq
Industry
Pharmaceutical Preparations
Location
3891 Ranchero Drive, Suite 150, Ann Arbor, MI

Insiders trading volume in the past year

Esperion Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Biotech Target N V 10%+ Owner $5.58M May 24, 2021
Sheldon L. Koenig President and CEO, Director $2.39M -$26.1K -1.08% Sep 17, 2024
Joanne M. Foody Chief Medical Officer $1.03M -$11.8K -1.13% Jul 17, 2024
Eric Warren Chief Commercial Officer $533K -$13.1K -2.39% Sep 17, 2024
Benjamin Halladay Chief Financial Officer $416K Mar 14, 2024
Richard Bartram Chief Financial Officer $361K Mar 14, 2022
Benjamin Looker General Counsel $347K Mar 14, 2024
J. Martin Carroll Director $213K May 23, 2024
Alan Fuhrman Director $185K May 23, 2024
Gotto Antonio M Jr Md D Phil Director $181K May 23, 2024
Jay Shepard Director $181K May 23, 2024
Nicole Vitullo Director $151K May 23, 2024
Tracy M. Woody Director $147K May 23, 2024
Stephen Rocamboli Director $143K May 23, 2024
H. Fischer Seth Director $123K May 23, 2024
Jeffrey Berkowitz Director $61.6K May 26, 2022
Daniel Janney Director $59.8K May 27, 2021
Mark E. Mcgovern Director $35.4K May 27, 2021

Recent Insider Transactions by Companies or Individuals for Esperion Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.